Clinical Trial Update: Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing whether different prophylactic doses of intravenous tranexamic acid reduce blood loss during cesarean section.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage Following Cesarean Delivery
• Postpartum Hemorrhage

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Talkha Central Hospital | Conditions: Hemorrhage of Cesarean Section and/or Perineal Wound, Postpartum Hemorrhage | Phase 4 | Status: COMPLETED